Cite
GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression.
MLA
Lee, Seung-Jin, and Dong-Soon Im. “GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression.” International Journal of Molecular Sciences, vol. 22, no. 23, Dec. 2021. EBSCOhost, https://doi.org/10.3390/ijms222313084.
APA
Lee, S.-J., & Im, D.-S. (2021). GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression. International Journal of Molecular Sciences, 22(23). https://doi.org/10.3390/ijms222313084
Chicago
Lee, Seung-Jin, and Dong-Soon Im. 2021. “GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression.” International Journal of Molecular Sciences 22 (23). doi:10.3390/ijms222313084.